About FDA

OCE/Stakeholder Meetings


Past Events



  • December 1, 2017: Assessment of Cardiovascular Toxicities in Immuno-Oncology Trials. Meeting information#OCECardioOnc17 disclaimer icon
  • November 28, 2017: Defining Disease Recurrence and Harmonizing Conduct in Adjuvant Bladder and Kidney Cancer Trials. Meeting information#OCEGU17 disclaimer icon
  • November 13, 2017: Partners in Progress: Cancer Patient Advocates and FDA. Save the date: Meeting information
  • November 6, 2017: FDA-ASCO Public Workshop: Geriatric Oncology Workshop. Meeting information
  • October 10, 2017: FDA-AACR Liquid Biopsies in Oncology Drug and Device Development Part II. Meeting Information disclaimer icon
  • July 20, 2017: FDA-AACR Oncology Dose Finding Workshop. Meeting information: FDA; AACR disclaimer icon
  • May 3-5, 2017: Accelerating Anticancer Agent Development and Validation Workshop. Bethesda North Marriott Hotel and Conference Center, 5701 Marinelli Road, Bethesda, MD. Meeting information
  • April 25, 2017: FDA/C-Path Consortium Second Annual Workshop on Clinical Outcomes Assessments in Cancer Clinical Trials. Hyatt Regency Bethesda Hotel, One Bethesda Metro Center (7400 Wisconsin Avenue), Bethesda, MD. Meeting information 
  • Feb 23, 2017: FDA-ASCO: Hematology and Oncology Fellows Day Workshop. Meeting information

Information about events prior to 2017 can be found in the FDA Archive.

Page Last Updated: 02/20/2019
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English